Novel peptide–dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer
Jianfeng Liu1,2, Jinjian Liu2, Liping Chu2, Yanming Wang3, Yajun Duan1, Lina Feng2, Cuihong Yang1, Ling Wang3, Deling Kong11The Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Science, Nankai University, Tianjian, People's Republic of China; 2Tianjin Key Lab...
Guardado en:
Autores principales: | Liping Chu, Jinjian Liu, Jianfeng Liu, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d49dab07b98b4a788b5f38526dd0dc47 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transferrin Conjugated pH- and Redox-Responsive Poly(Amidoamine) Dendrimer Conjugate as an Efficient Drug Delivery Carrier for Cancer Therapy
por: Hu Q, et al.
Publicado: (2020) -
Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy
por: Narsireddy A, et al.
Publicado: (2015) -
Effectiveness of maintenance treatments for nonsmall cell lung cancer
por: Eadens MJ, et al.
Publicado: (2011) -
Enhancing cellular uptake of activable cell-penetrating peptide–doxorubicin conjugate by enzymatic cleavage
por: Shi NQ, et al.
Publicado: (2012) -
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer
por: Eduardo Lasalvia-Prisco, et al.
Publicado: (2008)